PPA
KDNY

Parametric Portfolio Associates’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Parametric Portfolio Associates’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-69,935
Closed -$808K – 3989
2020
Q2 		$808K Buy
+69,935
New +$964K ﹤0.01% 3034
2019
Q4 		– Sell
-4,071
Closed -$22K – 4011
2019
Q3 		$22K Sell
4,071
-5,714
-58% -$37.9K ﹤0.01% 3925
2019
Q2 		$75K Buy
9,785
+5,367
+121% +$81.7K ﹤0.01% 3874
2019
Q1 		$88K Buy
4,418
+1,638
+59% +$28.6K ﹤0.01% 3833
2018
Q4 		$37K Sell
2,780
-4,627
-62% -$92.4K ﹤0.01% 3866
2018
Q3 		$272K Sell
7,407
-212
-3% -$6.81K ﹤0.01% 3649
2018
Q2 		$267K Sell
7,619
-4,560
-37% -$175K ﹤0.01% 3599
2018
Q1 		$566K Buy
12,179
+4,880
+67% +$179K ﹤0.01% 3279
2017
Q4 		$274K Buy
7,299
+1,953
+37% +$85.3K ﹤0.01% 3610
2017
Q3 		$285K Sell
5,346
-279
-5% -$16.6K ﹤0.01% 3696
2017
Q2 		$321K Buy
5,625
+2,540
+82% +$127K ﹤0.01% 3603
2017
Q1 		$166K Buy
3,085
+424
+16% +$24K ﹤0.01% 3633
2016
Q4 		$152K Sell
2,661
-806
-23% -$48.8K ﹤0.01% 3653
2016
Q3 		$215K Buy
3,467
+939
+37% +$66.4K ﹤0.01% 3555
2016
Q2 		$143K Buy
+2,528
New +$154K ﹤0.01% 3678

Other funds holding KDNY

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Parametric Portfolio Associates's KDNY Position: Q3 2020 in Review

Parametric Portfolio Associates sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2020, closing a stake of 69,935 shares — an estimated $808K sold.

Parametric Portfolio Associates first reported a position in KDNY in Q2 2016 and held it in 15 quarters. The position peaked at $808K in Q2 2020. 70 funds tracked by Wall St. Rank hold KDNY as of Q3 2020.

  • Parametric Portfolio Associates reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 69,935 Chinook Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $808K.
  • Parametric Portfolio Associates first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2016 and held it in 15 quarters.
  • Parametric Portfolio Associates's Chinook Therapeutics, Inc. Common Stock position peaked at $808K in Q2 2020.
  • 70 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2020.

Based on Parametric Portfolio Associates's 13F filing for Q3 2020, filed 12 Nov 2020.